BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24916517)

  • 1. Overdiagnosis of gastro-esophageal reflux disease and underdiagnosis of functional dyspepsia in a USA community.
    Pleyer C; Bittner H; Locke GR; Choung RS; Zinsmeister AR; Schleck CD; Herrick LM; Talley NJ
    Neurogastroenterol Motil; 2014 Aug; 26(8):1163-71. PubMed ID: 24916517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease.
    Mönnikes H; Schwan T; van Rensburg C; Straszak A; Theek C; Sander P; Lühmann R
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1279-89. PubMed ID: 22486552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population.
    Rasmussen S; Jensen TH; Henriksen SL; Haastrup PF; Larsen PV; Søndergaard J; Jarbøl DE
    Scand J Gastroenterol; 2015 Feb; 50(2):162-9. PubMed ID: 25525975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria.
    Xiao YL; Peng S; Tao J; Wang AJ; Lin JK; Hu PJ; Chen MH
    Am J Gastroenterol; 2010 Dec; 105(12):2626-31. PubMed ID: 20823838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causal effect of anxiety and depression status on the symptoms of gastroesophageal reflux disease and functional dyspepsia during proton pump inhibitor therapy.
    Nakada K; Oshio A; Matsuhashi N; Iwakiri K; Kamiya T; Manabe N; Joh T; Higuchi K; Haruma K
    Esophagus; 2023 Apr; 20(2):309-316. PubMed ID: 36251168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study.
    Isshi K; Matsuhashi N; Joh T; Higuchi K; Iwakiri K; Kamiya T; Manabe N; Ogawa M; Arihiro S; Haruma K; Nakada K
    J Gastroenterol; 2019 Jun; 54(6):492-500. PubMed ID: 30673836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of overlap syndromes and symptoms in pediatric functional dyspepsia.
    Friesen CA; Rosen JM; Schurman JV
    BMC Gastroenterol; 2016 Jul; 16(1):75. PubMed ID: 27457769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between Tooth Loss, Functional Dyspepsia and Gastro-Esophageal Reflux Disorder among Isfahani Adults.
    Adibi P; Keshteli AH; Saneei M; Saneei P; Savabi O; Esmaillzadeh A
    Arch Iran Med; 2016 Feb; 19(2):123-30. PubMed ID: 26838083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett's esophagus.
    Neumann H; Monkemuller K; Kandulski A; Malfertheiner P
    Dig Dis; 2008; 26(3):243-7. PubMed ID: 18463443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Belching: dyspepsia or gastroesophageal reflux disease?
    Lin M; Triadafilopoulos G
    Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [PPI-test].
    Takahashi M; Katayama Y; Suzuki K; Tajima A; Oka S; Koizumi K; Ichimura H; Kuwayama H
    Nihon Rinsho; 2007 May; 65(5):852-63. PubMed ID: 17511224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.
    Raghunath AS; Hungin AP; Mason J; Jackson W
    Aliment Pharmacol Ther; 2009 Feb; 29(4):431-9. PubMed ID: 19035981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cigarette smoking and its association with overlapping gastroesophageal reflux disease, functional dyspepsia, or irritable bowel syndrome.
    Fujiwara Y; Kubo M; Kohata Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    Intern Med; 2011; 50(21):2443-7. PubMed ID: 22041340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease.
    De Vries DR; Van Herwaarden MA; Baron A; Smout AJ; Samsom M
    Scand J Gastroenterol; 2007 Aug; 42(8):951-6. PubMed ID: 17613924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of a modified Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease to distinguish functional dyspepsia from non-erosive reflux disease.
    Kusano M; Hosaka H; Kawada A; Kuribayashi S; Shimoyama Y; Kawamura O; Moki F
    J Gastroenterol Hepatol; 2012 Jul; 27(7):1187-91. PubMed ID: 22414314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States.
    Shaib Y; El-Serag HB
    Am J Gastroenterol; 2004 Nov; 99(11):2210-6. PubMed ID: 15555004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of coexisting upper gastrointestinal symptoms on daily life and quality of life in patients with gastroesophageal reflux disease symptoms.
    Isshi K; Furuhashi H; Koizumi A; Nakada K
    Esophagus; 2021 Jul; 18(3):684-692. PubMed ID: 33389239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey on the prevalence of GERD and FD based on the Montreal definition and the Rome III criteria among patients presenting with epigastric symptoms in Japan.
    Ohara S; Kawano T; Kusano M; Kouzu T
    J Gastroenterol; 2011 May; 46(5):603-11. PubMed ID: 21359521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of upper gastrointestinal symptoms in Brazil (EpiGastro): a population-based study according to sex and age group.
    do Rosário Dias de Oliveira Latorre M; Medeiros da Silva A; Chinzon D; Eisig JN; Dias-Bastos TR
    World J Gastroenterol; 2014 Dec; 20(46):17388-98. PubMed ID: 25516650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease.
    Bytzer P; Jones R; Vakil N; Junghard O; Lind T; Wernersson B; Dent J
    Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1360-6. PubMed ID: 22813439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.